merck pitches hepatitis c drug to u.s. fda panel
an experimental drug for the liver-damaging hepatitis c virus offers an advance over the current decade-old treatment that cures only a minority of patients, maker merck &amp; co told a u.s. advisory panel on wednesday.
http://feeds.reuters.com/~r/reuters/healthnews/~3/hgsox_zpiey/us-merck-hepatitis-idustre73q53u20110427
6571
27 Apr 2011 17:08:20
reuters
health